Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hyperthermia × Cryotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Warts 10 Breast Neoplasms 10 Prostatic Neoplasms 9 Keratosis, Actinic 9 Uterine Cervical Dysplasia 6 Peripheral Nervous System Diseases 6 Retinoblastoma 5 Stomatitis 4 Neoplasms 4 Lung Neoplasms 3 Esophageal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Hepatocellular 3 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Papillomavirus Infections 2 Pancreatic Neoplasms 2 Pain 2 Neoplasm Metastasis 2 Mucositis 2 Melanoma 2 Keratosis 2 Deglutition Disorders 2 Carcinoma, Ductal, Breast 2 Wilms Tumor 1 Ulcer 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Retinal Neoplasms 1

Interventions

Diathermy 17 Radiotherapy 10 Drug Therapy 4 Cisplatin 4 Radiation 3 Immune Checkpoint Inhibitors 3 Fluorouracil 3 Brachytherapy 3 tislelizumab 2 Surgical Procedures, Operative 2 Immunotherapy 2 Conization 2 spartalizumab 1 anlotinib 1 Solutions 1 Radiation Dose Hypofractionation 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Mitomycin 1 Ifosfamide 1 Hyperthermic Intraperitoneal Chemotherapy 1 Hyperthermia, Induced 1 Hydrogen Peroxide 1 Gemcitabine 1 Folfox protocol 1 Doxorubicin 1 Docetaxel 1 Dacarbazine 1 Cytoreduction Surgical Procedures 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04778631 2025-11-20

PERISAFE

Assistance Publique - Hôpitaux de Paris

Phase NA Completed

Hyperthermia, Agnosia, Neoplasm Metastasis, Pelvic Pain, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡